Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

The treatment combination is effective and generally safe for lung cancer.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

The rash resolved after stopping ponatinib.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Entospletinib effectively prevents eye and skin GVHD in mice.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Tofacitinib might be used to treat hair loss.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

JAK inhibitors may help improve symptoms in adults with APECED.